Clinical Trials Update: Nov. 24, 2008 U.S. News & World Report, DC - Nov 24, 2008 If you have moderate-to-severe active ulcerative colitis, and are being treated with or have failed treatment with: oral 5-aminosalicylates, ...
Source: Google News
Recent News and Articles on the Keywords: update + 2005 + 0.24 Related to the article below (Last Update: 8/5/2008)
Radio One, Inc. Reports Second Quarter Results Trading Markets (press release), CA - Radio One does not undertake any duty to update any forward-looking statements. Net revenue increased to approximately $83.4 million for the quarter ended ...ROIAK
Ore Reserve and Mineral Resource Update MarketWatch - Jul 8, 2008 These two veins have to date formed the majority of the 95000 ounces gold equivalent mine production at Palito since the beginning of 2005. ...ASX:MIN - LON:SRB
Ore Reserve and Mineral Resource Update Ad-Hoc-News (Pressemitteilung), Germany - Jul 8, 2008 These two veins have to date formed the majority of the95,000 ounces gold equivalent mine production at Palito since thebeginning of 2005. ...ASX:MIN - LON:SRB
Protein?protein docking benchmark 2.0: an update - J Mintseris, K Wiehe, B Pierce, R Anderson, R Chen … - Proteins, 2005 - doi.wiley.com ... new version of the benchmark is more of a reconstruction than an update. ...2005
WILEY-LISS, INC. ... N AB 1NCA_HL FAB 7NN9_ Flu virus neuraminidase N9 0.24 1953 ...
The Human Gene Map for Performance and Health-Related Fitness Phenotypes: The 2005 Update. - T RANKINEN, MS BRAY, JM HAGBERG, L P?RUSSE, SM … - Medicine & Science in Sports & Exercise, 2006 - acsm-msse.org ... It is also our hope that the yearly update of the fitness and performance ... V: 0.058
V: 0.048 U: 0.21 U: 0.24 K: 0 K: 0.045 T: 0.058 T ... HUMAN FITNESS GENE MAP 2005...
[PDF]Costs of US Oil Dependence: 2005 Update - DL Greene, S Ahmad - ORNL/TM, 2005 - environment.hawaiiresourcelibrary.com ... Costs of US Oil Dependence: 2005Update January 2005... COSTS OF US OIL DEPENDENCE: 2005UPDATE David L. Greene Oak Ridge National Laboratory Oak Ridge, Tennessee ...
Concordance for multiple sclerosis in Danish twins: an update of a nationwide study - T Hansen, A Skytthe, E Stenager, HC Petersen, H … - Multiple Sclerosis, 2005 - msj.sagepub.com ... by Heltberg and Holm, 11 and thus constitutes an update hereof. ... Multiple Sclerosis ? 2005 SAGE Publications ... MZ 203.0 (66.6? / 616.6) 0.016 0.24 (0.05? / 0.39 ...
[PDF]Update on Thai Publications in ISI Databases (1999-2005) MRJ Svasti, R Asavisanu - 2006 - scienceasia.org ...Update on Thai Publications in ISI Databases ... 103 Table 2. Share of World Publications
in ISI-WOS Databases for 2005 a . ... 42 Egypt 2,910 0.24 92 Moldova 204 0.02 ...
Sea Scallop Stock Assessment Update for 2005. US Dep. Commer DR Hart - Northeast Fish. Sci. Cent. Ref. Doc, 2006 - nefsc.noaa.gov ... Sea Scallop Stock Assessment Update for 2005... varied between 0.18 and 0.34; it was
0.22 in 2005, slightly under the overfishing threshold of 0.24, but just ...
Source: Google Scholar
Clinical Trials Update: Sept. 22, 2005
September 22, 2005 08:41:11 PM PST
Here are the latest clinical trials, courtesy of CenterWatch:
Yeast Infections
If you're suffering from symptoms of yeast or a bacterial infection, such as vaginal itching, burning, or irritation you may qualify for this clinical trial. Volunteers should be generally healthy, at least 18 years old, not pregnant or lactating, agree to abstain from intercourse during treatment and agree to use an effective, non-prohibited form of birth control after treatment, if of childbearing potential. Research site located in San Diego, Calif.
The study medication is given by shallow injection under the skin next to each armpit and each groin. The injections are given every two weeks for the first five visits, then every four weeks for the rest of the year. There are a total of 15 injection visits. Patients showing no evidence of response at week 24 will receive no further treatment with Canvaxin, the study medication. Research site located in Tampa, Fla.
This study is seeking patients between the ages of 18 and 70 with a doctor's diagnosis of bipolar I disorder with manic or mixed episodes. Participants must meet be 18 to 70 with diagnosis of bipolar disorder (type I), manic or mixed episodes and in need of psychiatric treatment. Research sites located in Illinois and Oklahoma.
